David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.9B |
| 2 |
Broadcom
AVGO
|
+$1.07B |
| 3 |
NVIDIA
NVDA
|
+$908M |
| 4 |
Meta Platforms (Facebook)
META
|
+$861M |
| 5 |
Intuitive Surgical
ISRG
|
+$666M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.68B |
| 2 |
Apple
AAPL
|
+$1.31B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$789M |
| 4 |
GE Aerospace
GE
|
+$653M |
| 5 |
Applovin
APP
|
+$634M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 38.56% |
| 2 | Technology | 19.25% |
| 3 | Consumer Discretionary | 7.51% |
| 4 | Financials | 7.11% |
| 5 | Healthcare | 6.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TDACU
2376
Translational Development Acquisition Corp Units
TDACU
| $3.64M | ﹤0.01% |
350,000
| – | – |
|
2377
Yext
YEXT
$678M
| $3.64M | ﹤0.01% |
427,051
-437,072
| -51% | -$3.71M |
|
2378
PUT
Emcor
EME
$34.2B
| $3.64M | ﹤0.01% |
5,600
+600
| +12% | +$364K |
|
2379
Afya
AFYA
$1.27B
| $3.64M | ﹤0.01% |
233,159
-71,900
| -24% | -$1.1M |
|
2380
CALL
Viking Therapeutics
VKTX
$3.95B
| $3.64M | ﹤0.01% |
138,400
+114,900
| +489% | +$3.43M |
|
2381
CALL
RH
RH
$2.74B
| $3.64M | ﹤0.01% |
17,900
-113,900
| -86% | -$24.7M |
|
2382
PUT
Valaris
VAL
$5.93B
| $3.63M | ﹤0.01% |
74,400
+1,600
| +2% | +$78K |
|
2383
Kanzhun
BZ
$8.04B
| $3.63M | ﹤0.01% |
155,293
+79,491
| +105% | +$1.71M |
|
2384
CALL
Constellation Brands
STZ
$22.4B
| $3.62M | ﹤0.01% |
26,900
-19,400
| -42% | -$3.09M |
|
2385
Tango Therapeutics
TNGX
$4.26B
| $3.62M | ﹤0.01% |
+430,379
| New | +$2.91M |
|
|
VRE
2386
DELISTED
Veris Residential
VRE
| $3.61M | ﹤0.01% |
237,798
-226,599
| -49% | -$3.37M |
|
2387
Medifast
MED
$136M
| $3.6M | ﹤0.01% |
263,648
-57,581
| -18% | -$804K |
|
2388
CALL
IMAX
IMAX
$2.85B
| $3.6M | ﹤0.01% |
110,000
| – | – |
|
|
EMA
2389
CALL
Emera Inc
EMA
$15.4B
| $3.6M | ﹤0.01% |
75,000
| – | – |
|
2390
Regions Financial
RF
$25.9B
| $3.6M | ﹤0.01% |
136,399
-1,942,462
| -93% | -$50.5M |
|
|
TDAC
2391
Translational Development Acquisition Corp
TDAC
$209M
| $3.59M | ﹤0.01% |
346,900
| – | – |
|
2392
Kornit Digital
KRNT
$727M
| $3.59M | ﹤0.01% |
265,656
-21,183
| -7% | -$360K |
|
2393
PUT
Marathon Petroleum
MPC
$102B
| $3.58M | ﹤0.01% |
18,600
-4,100
| -18% | -$721K |
|
2394
CALL
KeyCorp
KEY
$23.5B
| $3.58M | ﹤0.01% |
+191,700
| New | +$3.55M |
|
2395
CALL
GeneDx Holdings
WGS
$2.66B
| $3.58M | ﹤0.01% |
33,200
+1,000
| +3% | +$109K |
|
2396
GCM Grosvenor
GCMG
$836M
| $3.57M | ﹤0.01% |
295,945
-11,696
| -4% | -$145K |
|
2397
Costamare
CMRE
$1.86B
| $3.56M | ﹤0.01% |
299,186
+113,426
| +61% | +$1.24M |
|
2398
PUT
Samsara
IOT
$24.4B
| $3.56M | ﹤0.01% |
95,500
+49,500
| +108% | +$1.84M |
|
2399
Dave & Buster's
PLAY
$319M
| $3.56M | ﹤0.01% |
195,820
-115,769
| -37% | -$3.04M |
|
2400
PUT
Pagaya Technologies
PGY
$1.94B
| $3.55M | ﹤0.01% |
119,700
+77,700
| +185% | +$2.51M |
|
Similar funds
David Shaw's Q3 2025 Portfolio in Review
As of Q3 2025, David Shaw held 5,023 positions worth $177B, up 26% from $141B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
David Shaw deployed $8.01B of net new capital in Q3 2025, opening 714 new positions and adding to 1,743 existing holdings. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 3,319,000 shares worth $370M.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, down from 39% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.68B trimmed.
- David Shaw's largest Q3 2025 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 3,319,000 shares worth $370M.
- David Shaw added most to Microsoft in Q3 2025, an estimated $1.9B increase.
- David Shaw's biggest Q3 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.68B.
- David Shaw fully exited Hess in Q3 2025, selling an estimated $527M.
- David Shaw's ten largest holdings make up 13% of its $177B portfolio in Q3 2025.
- David Shaw opened 714 new positions and closed 514 in Q3 2025.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $177B.
Based on D.E. Shaw & Co's 13F filing for Q3 2025, filed 14 Nov 2025.